PMDA drug package insert
サブパック血液ろ過用補充液−Bi
PMDA Prescription drug · ニプロ株式会社 · package insert Sep 16, 2026
Key facts
| Brand names | サブパック血液ろ過用補充液−Bi |
|---|---|
| Nonproprietary names | 人工透析液 |
| Companies | 製造販売元／ニプロ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ろ過型人工腎臓用補液・持続的血液浄化液 |
| Therapeutic category codes | 87341 |
| YJ codes | 3410534G2038 |
| Approval numbers | 22000AMX01559 |
| Package insert edition | 第2版 |
| Package insert date | Sep 16, 2026 |
| PMDA document key | 530100_3410534G2038_1 |
| PMDA company code | 530100 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: